Olema Oncology - Ownership and Business Overview

Life ScienceCompany

Olema Oncology Ownership

Who owns Olema Oncology?

.

Olema Oncology Business Overview

Where is Olema Oncology headquartered?

Olema Oncology is headquartered in San Francisco, California.

What is Olema Oncology’s revenue?

Olema Oncology disclosed revenue of 105M USD for 2023 and 107M USD for 2022.

How many employees does Olema Oncology have?

Olema Oncology has 80 employees.

What sector is Olema Oncology in?

Olema Oncology is a life science company.

When was Olema Oncology founded?

Olema Oncology was founded in 2006.

Life Science M&A Summary in

Join Mergr to view all 0 acquisitions of life science companies in , including .

Olema Oncology

Olema Pharmaceuticals, Inc.

780 Brannan Street,
San Francisco, California 94103
United States,
(415) 651-3316
www.olema.com

Olema Oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. The company's lead program, OP-1250, a potential best-in-class complete estrogen receptor antagonist (CERAN), is in development to treat estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Olema recently initiated a Phase 1/2 dose-escalation and expansion clinical trial of OP-1250. Olema Oncology was formed in 2006 and is based in San Francisco, California.


 Subscribe to unlock this and 208,718
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 204K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.